Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vistagen Therapeutics (VTGN) Prepaid Assets (2016 - 2025)

Vistagen Therapeutics' Prepaid Assets history spans 12 years, with the latest figure at $1.5 million for Q4 2025.

  • For Q4 2025, Prepaid Assets rose 6.81% year-over-year to $1.5 million; the TTM value through Dec 2025 reached $1.5 million, up 6.81%, while the annual FY2025 figure was $1.6 million, 5.84% up from the prior year.
  • Prepaid Assets for Q4 2025 was $1.5 million at Vistagen Therapeutics, down from $1.8 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $3.5 million in Q2 2025 and bottomed at $875700.0 in Q1 2021.
  • The 4-year median for Prepaid Assets is $1.6 million (2025), against an average of $1.9 million.
  • The largest annual shift saw Prepaid Assets surged 289.03% in 2021 before it dropped 25.78% in 2025.
  • A 4-year view of Prepaid Assets shows it stood at $2.7 million in 2021, then tumbled by 44.7% to $1.5 million in 2023, then decreased by 6.71% to $1.4 million in 2024, then increased by 6.81% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for VTGN's Prepaid Assets are $1.5 million (Q4 2025), $1.8 million (Q3 2025), and $3.5 million (Q2 2025).